SM
Susan Mahony

Susan Mahony insider trades: Axsome Therapeutics (AXSM) stock sales

Axsome Therapeutics Last trade Jun 10, 2026 58 Form 4 filings
$145K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2012
6
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Susan reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 10, 2026AXSM↓ Sell$145K
Apr 16, 2018LLY↓ Sell$1.8M
Dec 4, 2017LLY↓ Sell$3.2M
Dec 16, 2016LLY↓ Sell$1.4M
Dec 16, 2016LLY↓ Sell$84K
Jul 28, 2015LLY↓ Sell$2.1M
Jul 28, 2014LLY↓ Sell$131K
Jul 25, 2014LLY↓ Sell$1.9M
Apr 29, 2013LLY↓ Sell$197K
Mar 26, 2013LLY↓ Sell$280K
Feb 1, 2013LLY↓ Sell$271K
Oct 24, 2012LLY↓ Sell$505K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other AXSM insiders

Open-market trades in the last 12 months

About Susan Mahony's insider trades

Susan Mahony is an insider at Axsome Therapeutics (AXSM). Since Oct 24, 2012, Susan has reported no open-market purchases and 12 sales worth $12.0M on SEC Form 4. In the last 12 months: 1 sale ($145K).

Their filings also include grants and awards (36 filings), option exercises (16 filings), shares withheld for taxes (14 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AXSM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.